Genes & Diseases2026，Vol.13Issue(3)：P.591-606,16.DOI:10.1016/j.gendis.2025.101756
HSP90B1 facilitates glioma radiotherapy resistance by regulating RhoC ubiquitin‒proteasome degradation
Jiacheng Xu 1Yuduo Guo 2Jingjing Yang 3Guanjie Shang 3Weihai Ning 3Deshan Liu 3Hongwei Zhang 3Yongmei Song4
作者信息
- 1. State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China Department of Neurosurgery,Sanbo Brain Hospital,Capital Medical University,Beijing 100093,China
- 2. Department of Neurosurgery,Xuanwu Hospital,Capital Medical University/China International Neuroscience Institute (China-INI),Beijing 100053,China
- 3. Department of Neurosurgery,Sanbo Brain Hospital,Capital Medical University,Beijing 100093,China
- 4. State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
- 折叠
摘要
关键词
Glioma/Heat shock proteins/HSP90B1/Radiotherapy/RhoC分类
医药卫生引用本文复制引用
Jiacheng Xu,Yuduo Guo,Jingjing Yang,Guanjie Shang,Weihai Ning,Deshan Liu,Hongwei Zhang,Yongmei Song..HSP90B1 facilitates glioma radiotherapy resistance by regulating RhoC ubiquitin‒proteasome degradation[J].Genes & Diseases,2026,13(3):P.591-606,16.基金项目
The National Natural Science Foundation of China(No.82101932)financed this research. （No.82101932）
